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G R A P H I C A L A B S T R A C T
A B S T R A C T
In this work, two analytical methodologies based on liquid chromatography coupled to tandem mass
spectrometry (LC–MS/MS) were developed for quantiﬁcation of emerging pollutants identiﬁed in sewage sludge
after a previous wide-scope screening. The target list included 13 emerging contaminants (EC): thiabendazole,
acesulfame, fenoﬁbric acid, valsartan, irbesartan, salicylic acid, diclofenac, carbamazepine, 4-aminoantipyrine (4-
AA), 4-acetyl aminoantipyrine (4-AAA), 4-formyl aminoantipyrine (4-FAA), venlafaxine and benzoylecgonine. The
aqueous and solid phases of the sewage sludge were analyzed making use of Solid-Phase Extraction (SPE) and
UltraSonic Extraction (USE) for sample treatment, respectively. The methods were validated at three
concentration levels: 0.2, 2 and 20 mg L1 for the aqueous phase, and 50, 500 and 2000 mg kg1 for the solid
phase of the sludge. In general, the method was satisfactorily validated, showing good recoveries (70–120%) and
precision (RSD < 20%). Regarding the limit of quantiﬁcation (LOQ), it was below 0.1 mg L1 in the aqueous phase
and below 50 mg kg1 in the solid phase for the majority of the analytes. The method applicability was tested by
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3nalysis of samples from a wider study on degradation of emerging pollutants in sewage sludge under anaerobic
igestion.
The key beneﬁts of these methodologies are:
 SPE and USE are appropriate sample procedures to extract selected emerging contaminants from the aqueous
hase of the sewage sludge and the solid residue.
 LC–MS/MS is highly suitable for determining emerging contaminants in both sludge phases.
 Up to our knowledge, the main metabolites of dipyrone had not been studied before in sewage sludge.
 2016 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY license (http://
creativecommons.org/licenses/by/4.0/).
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ethod details
The methods developed in this work were applied to investigate the presence of selected emerging
ontaminants in the aqueous and solid phases of sewage sludge. Both phases were analyzed
ndividually using an optimized extraction procedure for each one. The samples were collected after
naerobic digestion performed in an experimental sewage sludge treatment plant located in the
editerranean area, using two different types of anaerobic bacteria [1].
The analytes selected for this work were previously found in the sewage samples in a wide-scope
creening using UHPLC-QTOF MS [1]. Based on screening data, 13 emerging pollutants were selected
o perform quantitative analysis by LC–MS/MS: the fungicide thiabendazole (widely used as post-
arvest fungicide in citrus), and the pharmaceuticals carbamazepine (used as a treatment of epilepsy),
enlafaxine (anti-depressant), irbesartan and valsartan (used to treat high blood pressure) and the
on-steroidal anti-inﬂammatory diclofenac. Moreover, some metabolites were also selected, such as
alicylic acid (which is the main metabolite of acetylsalicylic acid [2,3]) and three metabolites of the
nalgesic dipyrone [3–5] (4-aminoantipyrine (4-AA), 4-acetyl aminoantipyrine (4-AAA) and 4-formyl
minoantipyrine (4-FAA)). Benzoylecgonine (BE), the main metabolite of cocaine, was also considered
s this compound, found in the screening of samples at high abundance, is commonly present at high
oncentrations in urban wastewaters [6,7].
ludge samples origin
The samples were collected from October 2014 to January 2015 in a pilot sludge digestion plant
ocated in the Mediterranean area. Inﬂuent sewage sludge samples were collected as 24-h composite
f the feeding tank, and grab samples were collected after anaerobic digestion. Samples were frozen at
24 C immediately after collection. The analyte concentrations were obtained in the aqueous and
olid phase of the sludge, in order to estimate the pollutant distribution in both phases [1].
ample treatment
Sewage sludge samples contained approximately 2% (w/w) of suspended solids (solid phase). This
ercentage varied slightly depending on the sample. Before analysis, raw sludge samples were thawed
t room temperature, and the aqueous and solid phases separated by decantation. The aqueous phase
as centrifuged and the supernatant was subjected to SPE for pre-concentration, clean-up and
xtraction [8–11]. In relation to the solid phase, it was lyophilized under vacuum in order to eliminate
he residual water and preserve its integrity. An ultrasonic assisted extraction (USE) procedure
12–16], was then applied for extraction of analytes in the lyophilized solid residue of the sludge.
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Aqueous phase of the sludge
Water samples were centrifuged at 4600 rpm for 10 min in falcon tubes using a Consul21 centrifuge
(Ortoalresa, Madrid, Spain). 50 mL of supernatant was spiked at 0.1 mg L1 with the mix of ILIS
compounds measured in ESI+, and at 0.4 mg L1 with salicylic acid-d4 which is monitored in ESI-.
SPE was performed using Oasis HLB 200 mg cartridges, previously conditioned with 6 mL MeOH
and 6 mL Milli-Q water. Samples were two-fold diluted with Milli-Q water and percolated through the
cartridges by gravity. After drying under vacuum, the analytes were eluted with 10 mL MeOH. The
extracts were evaporated to dryness under vacuum at 60 C using a miVac DUO concentrator
(GeneVac, Suffolk, UK) and ﬁnally reconstituted with 1 mL MeOH:water (10:90, v/v). The ﬁnal extracts
were centrifuged in Eppendorf tubes at 12000 rpm for 10 min (Centronic-BL, Selecta, Barcelona,
Spain), and the supernatants were transferred into LC vials, and injected in the LC–MS system. (For
further details about SPE optimization see SI).
Solid phase of the sludge
Lyophilized solid phase was homogenized using a glass mortar. 0.1 g of homogenized solid residue
were accurately weighted (precision 0.1 mg) directly in Eppendorf tubes and spiked at 0.05 mg kg1
with the mix of ILIS compounds measured in ESI+, and at 0.2 mg kg1 with salicylic acid-d4 which is
monitored in ESI-. Afterwards, it was extracted with 2 mL of MeOH:water (50:50) 0.5% HCOOH, using a
Vortex (Heidolph Instruments, Schabach, Germany) for 1 min. After that, samples were sonicated
15 min at 40 kHz (Selecta Ultrasons, Selecta, Barcelona, Spain) and centrifuged at 12000 rpm for
10 min. The supernatant was collected into a glass tube, and the extraction procedure was repeated.
Both supernatants were mixed and evaporated to dryness under vacuum at 60 C using a miVac DUO
concentrator, and ﬁnally reconstituted with 1 mL of MeOH:water (10:90, v/v). The ﬁnal extract was
centrifuged at 12000 rpm for 10 min and transferred into a LC vial for its injection in the LC–MS. (For
further details about USE optimization see SI).
Materials and instrumentation
The list of the target compounds for instrumental method development is presented in Table 1.
Reference standards were purchased from Toronto Research Chemicals (Ontario, Canada), Sigma-
Aldrich (St Louis, MO, USA), LGC Promochem (London, UK), Across Organics (Geel, Belgium), Bayer
Hispania (Barcelona, Spain), Fort Dodge Veterinaria (Gerona, Spain), Aventis Pharma (Madrid, Spain)
and Vetoquinol Industrial (Madrid, Spain). Benzoylecgonine (BE) was obtained from Cerilliant (Round
Rock, TX, USA).
Regarding Isotopically-Labeled Internal Standards (ILIS), benzoylecgonine-d3 was purchased from
Cerilliant as solution in methanol at a concentration of 100 mg L1. The rest of the ILIS (Table 1) were
purchased from CDN Isotopes (Quebec, Canada).
Formic acid (HCOOH, content > 98%), HPLC-grade methanol (MeOH), HPLC-grade acetonitrile
(ACN), sodium hydroxide (NaOH, >99%) and ammonium acetate (NH4Ac) were acquired from Scharlab
(Barcelona, Spain). HPLC-grade water was obtained from deionized water passed through a Milli-Q
Gradient A10 (18.2 MV cm) water puriﬁcation system (Millipore, Bedford, MA, USA).
Solid-phase extraction (SPE) cartridges (Oasis HLB; 200 mg) were purchased from Waters (Milford,
MA, USA).
The analytical instrumentation consisted of a Waters Alliance HT 2795 high performance liquid
chromatography (HPLC) system (Waters, Mildford, MA, USA), equipped with a quaternary solvent
manager and a sample manager coupled to a triple quadrupole mass spectrometer Quattro Micro API
MS (Waters) equipped with an orthogonal Z-spray electrospray ionization interface (ESI) operated in
both positive and negative ion modes.
Cone gas as well as desolvation gas was nitrogen (Praxair, Valencia, Spain) set up 60 L h1 and 600 L
h1, respectively. For operation in the MS/MS mode, collision gas was argon with 99.995% purity
(Praxair, Valencia, Spain). Other parameters optimized were capillary voltage 3.5 kV (ESI + ) and 3 kV
(ESI-), source temperature 120 C and desolvation temperature 350 C. The cone voltage was
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3ptimized for each compound. Dwell times of 0.1 s were selected as a compromise between sensitivity
nd number of points per peak.
Chromatographic separation was performed using a Symmetry C18 analytical column
50  2.1 mm, 3.5 mm particle size, Waters). A gradient consisting of water (solvent A) and MeOH
solvent B) both with 0.1 mM NH4Ac and 0.01% HCOOH was used as mobile phase. The percentage of
eOH was changed linearly as follows: 0 min, 10%; 6 min, 90%; 7 min, 90%; 7.1 min, 10%. The total run
ime was 12 min. The ﬂow rate was 300 mL min1. The sample injection volume was 20 mL.
All data were acquired and processed using MassLynx version 4.1 (Waters). The quantiﬁcation
rocess was performed using TargetLynx application manager (Micromass v4.1).
C–MS optimization
In this work, different mobile phases (water, MeOH and acetonitrile) with different additives
HCOOH and NH4Ac) were tested. The effect of pH and ionic strength of mobile phase on peak shape,
esolution and peak area were evaluated by varying the modiﬁer concentration.
MS/MS parameters such as Selected Reaction Monitoring (SRM) transitions, cone voltage and
ollision energy as well as retention time are listed in Table 1. For the MS/MS optimization, individual
tandard solutions were directly infused in the triple quadrupole (QqQ). Most of the compounds
10 out of 13) were determined in ESI operating in positive ionization mode, using the protonated
olecule [M + H]+ as precursor ion. The 3 remaining compounds were determined in negative
onization mode, using the deprotonated molecule [M-H] as precursor ion. The two most intense
RM transitions (in terms of peak area) were selected for each compound: the most abundant product
on was used for quantiﬁcation (Q) and one additional product ion was used for conﬁrmation (q)
Table 1). Regarding ILISs, only the most intense transition was monitored.
atrix effects
Severe matrix effects were observed due to the complexity of the samples, mostly leading to
onization suppression. In order to avoid complicated sample treatment with clean-up steps, we used
LIS for correction of the signal suppression ensuring an accurate quantiﬁcation [9,17]. In addition,
sing ILIS as surrogate, potential analyte losses during sample treatment could be also corrected. In
able 1
S/MS optimized conditions for selected compounds.
Compound ESI RT
(min)
Cone
(V)
Q
transition
CE
(eV)
q
transition
CE
(eV)
4-AA + 3.91 20 204.4 > 83.1 15 204.4 > 159.1 10
4-AAA + 4.58 20 246.3 > 228.3 20 246.3 > 83.1 20
4-FAA + 4.55 20 232.2 > 83.1 20 232.2 > 104.1 20
Acesulfame – 6.32 20 162.2 > 82.0 15 162.2 > 77.9 30
BE + 5.26 30 290.2 > 168.2 20 290.2 > 105.1 30
Carbamazepine + 7.13 30 237.3 > 194.4 20 237.3 > 192.4 45
Diclofenac + 8.51 20 296.2 > 214.2 30 296.2 > 278.1 10
Fenoﬁbric Acid – 8.71 20 317.2 > 231.2 20 317.2 > 195.3 35
Irbesartan + 7.98 30 429.3 > 207.4 25 429.3 > 195.4 20
Salicylic Acid – 7.50 20 137.1 > 93.1 15 137.1 > 65.0 25
Thiabendazole + 4.80 40 202.3 > 175.2 25 202.3 > 131.2 30
Valsartan + 8.21 20 436.2 > 235.3 20 436.2 > 207.2 25
Venlafaxine + 5.08 20 278.4 > 57.8 15 278.4 > 260.4 10
BE-d3 + 5.26 30 293.3 > 171.2 20
Diclofenac-d4 + 8.51 20 300.1 > 219.2 20
Irbesartan-d6 + 7.98 30 435.3 > 213.4 25
Salicylic Acid-d4 – 7.50 20 141.1 > 97.1 15
Thiabendazole-d6 + 4.80 40 208.3 > 136.0 30
Valsartan-d8 + 8.21 20 444.3 > 291.2 20
Venlafaxine-d6 + 5.08 20 284.3 > 63.9 15
SI: electrospray ionization; RT: retention time; Q: quantiﬁcation transition; q: conﬁrmation transition; CE: collision energy.
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total, 7 ILIS (thiabendazole-d6, venlafaxine-d6, BE-d3, irbesartan-d6, valsartan-d8, diclofenac-d4 and
salicylic acid-d4) were used for quantiﬁcation of their corresponding analytes, while 4 more
compounds were quantiﬁed using analogue ILIS, BE-d3 for the quantiﬁcation of 4-AA, 4-FAA and
4-AAA and irbesartan-d6 for carbamazepine. In this case, the selection of the analogue ILIS was mainly
based on retention time similarity between analyte and ILIS, in order to facilitate that both compounds
were affected by similar constituents of the matrix. The remaining 2 compounds, acesulfame and
fenoﬁbric acid, could not be properly corrected by any ILIS available in our laboratory.
Method validation
The two methodologies developed for the determination of the 13 selected emerging compounds
in the aqueous and solid phase of sewage sludge were ﬁnally validated.
The linearity of the method was studied by injecting different concentration levels in duplicate in
the range 0.05–500 mg L1, establishing the adequate lineal range for each compound (see Table 2).
Calibration curves showed, in all cases, correlation coefﬁcients (r) greater than 0.99, based on relative
responses (analyte peak area/ILIS peak area), and residuals lower than 10%.
Method accuracy (estimated by means of recovery experiments in spiked samples) and precision
(expressed as repeatability, in terms of Relative Standard Deviation (RSD)) were evaluated in samples
spiked at three concentration levels: 0.2, 2 and 20 mg L1 for the aqueous phase, and 50, 500 and
2000 mg kg1 for the solid phase. The concentration levels tested in this work were selected based on
those estimated from the previous LC-QTOF screening performed in the samples. These values were in
the line of sewage sludge concentrations reported in most of the published papers, commonly from
40 to 25000 mg kg1 [12,15,18,19]. Both sludge phases were spiked before the sample treatment. The
experiments were performed in triplicates (n = 3) for each matrix and each spiking level. As almost all
the non-spiked samples used in the validation study contained the target analytes, the concentrations
found in these samples were subtracted from those found in spiked samples. Satisfactory recoveries
values between 70% and 120%, with RSD lower than 20% were obtained for all contaminants, with
some exceptions (see Table 2). For the 4-AA, recovery values lower than 40% were obtained in both
sludge phases at all the spiking levels tested. These poor recoveries could be explained as the use of an
analogue ILIS (BE-d3) could not completely compensate for the matrix effect obtained. Some
compounds (4-AAA, 4-FAA, carbamazepine, salicylic acid, thiabendazole, valsartan and venlafaxine)
presented RSD higher than 20%, for at least one spiking level. Despite of that, all of these values were
lower than 25%, except for thiabendazole in the aqueous phase (42%). It could be originated by the high
concentration of this analyte in the samples used as “blank”, which could increase the RDS of the
replicates of spiked samples. At the lowest level, several compounds in both aqueous phase and solid
phase could not be validated, due to the high analyte concentration found in the non-spiked samples.
Fig. 1 shows LC–MS/MS chromatograms (quantiﬁcation transition) for the seven compounds that
could be validated at the lowest level in the solid phase of the sewage sludge.
The limit of quantiﬁcation (LOQ) was estimated for a signal to noise (S/N) ratio 10 from the sample
chromatograms at the lowest validation level tested (n = 3), using the quantiﬁcation transition. As
experiments were performed in real-world sewage sludge, no blank samples were available for most
of analytes. In those cases, LOQ values were estimated from the chromatograms of the non-spiked
samples taking into account the concentration levels found in them. As can be seen in Table 2, most
LOQs were below 0.1 mg L1 and 50 mg kg1 in the aqueous and solid phases, respectively.
The calorie-free sweetener, acesulfame, and the main metabolite of the fenoﬁbrate, fenoﬁbric acid,
could not be properly corrected by any ILIS used; as a consequence, and due to the strong matrix effects
observed, they could not be satisfactory validated. For these compounds, absolute response of samples
were used to roughly evaluate trends in their possible degradation after sewage sludge treatment [1].
Conﬁrmation of the identity
Conﬁrmation of the identity of compounds in samples was based on the agreement in LC retention
time (0.2 min) and the “q/Q” intensity ratio (30%) in relation to the reference standard [20].
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Table 2
Results of the validation for aqueous and solid phases of sewage sludge. Limit of quantiﬁcation (LOQ), recovery (%) and relative standard deviation (RSD) at the three validation levels tested.
Compound Aqueous Phase (n = 3) Solid Phase (n = 3) ILIS
(Surrogate)
r
(lineal range,
mg L1)
% Recovery (RSD) LOQ
(ng L1)
% Recovery (RSD) LOQ
(mg kg1)
0.2mg L1 2mg L1 20mg L1 50mg kg1 500mg kg1 2000mgkg1
4-AA n.v. 37 (19) 27 (9) 99 n.v. 23 (23)a 20 (21) 11 BE-d3 0.993 (0.5–100)
4-AAA n.v. 106 (20) 93 (6) 33 76 (4)a 110 (24)a 92 (21) 46 BE-d3 0.999 (0.1–50)
4-FAA n.v. 101 (16) 99 (5) 96 97 (16) 105 (23)a 111 (14) 46 BE-d3 0.999 (0.1–50)
BE 103 (10) 96 (3) 94 (2) 9.3 88 (10) 86 (15) 90 (8) 15 BE-d3 0.999 (0.05500)
Carbamazepine 88 (23) 92 (21) 116 (8) 8.6 114 (11) 114 (13) 117 (14) 5.4 Irbesartan-d6 0.999 (0.05500)
Diclofenac n.v. 96 (1)a 99 (24)a 48 n.v. 114 (15) 98 (7) 63 Diclofenac-d4 0.999 (0.05500)
Irbesartan 107 (7) 98 (3) 103 (9) 14 80 (12) 90 (9) 97 (14) 1.2 Irbesartan-d6 0.999 (0.1–500)
Salicylic Acid n.v. n.v. 95 (22) 220 n.v. n.v. 109 (17) 35 Salicylic Acid-d4 0.995 (0.05500)
Thiabendazole n.v. n.v. 114 (42) 84 n.v. 122 (1)a 92 (11) 17 Thiabendazole-d6 0.999 (0.5–500)
Valsartan n.v. 105 (6)a 100 (4) 74 66 (8)a 76 (22) 100 (20) 27 Valsartan-d8 0.998 (0.25–500)
Venlafaxine 98 (21) 96 (2) 107 (6) 0.2 82 (24) 91 (15) 92 (19) 7.5 Venlafaxine-d6 0.999 (0.1–500)
n.v.: These compounds could not be validated as all the three samples used as “blank” contained high analyte concentration.
a Validation performed for n = 2, due to the high analyte concentration found in one of the three “blank” samples used for validation.
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Fig. 1. LC–MS/MS chromatograms for compounds at the lowest level validated (50mg kg1) in the solid phase of the sludge.
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